BALA CYNWYD, PA / ACCESSWIRE / October 22, 2019 / Brodsky & Smith, LLC reminds investors of important deadlines for lead plaintiff application regarding class action lawsuits against the following companies for violations of federal securities laws. If you purchased any of the below-listed stocks during the referenced time periods and want to discuss your legal rights, please contact Marc Ackerman, Esquire or Jordan Schatz, Esquire at 877-534-2590. There is no cost or financial obligation to you.
MATCH GROUP, INC. (NASDAQ:MTCH)
Shares purchased between August 6, 2019 and September 25, 2019
Deadline: December 2, 2019
The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that the Company used fake love interest ads to convince customers to buy and upgrade subscriptions; (2) that the Company made it difficult and confusing for consumers to cancel their subscriptions; (3) that, as a result, the Company was reasonably likely to be subject to regulatory scrutiny; (4) that the Company lacked adequate disclosure controls and procedures; and (5) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.
Additional information is available at http://www.brodskysmith.com/cases/match-group-inc-nasdaq-mtch/. No cost or obligation.
MYRIAD GENETICS, INC. (NASDAQ:MYGN)
Shares purchased between September 2, 2019 and August 13, 2019
Deadline: November 26, 2019
According to the complaint, throughout the Class Period, the defendants made false and/or misleading statements and/or failed to disclose that: (i) GeneSight lacked evidence or information sufficient to support the tests in their current form, including their purported benefits; (ii) the FDA had requested changes to GeneSight and questioned the validity of the test's purported benefits; (iii) Myriad had been in ongoing discussions with the FDA regarding the FDA's requested changes to GeneSight; (iv) Myriad's acquisition of Counsyl-and thereby, Foresight-caused Myriad to incur the risk of suffering from lower reimbursement for its expanded carrier screening tests, which had the potential to, and actually did, materialize into a material negative impact on Myriad's revenue; and (v) as a result, Myriad's public statements were materially false and misleading at all relevant times.
Additional information can be found at http://www.brodskysmith.com/cases/myriad-genetics-inc-nasdaq-mygn/, or call: 877-534-2590. No cost or obligation.
CAPITAL ONE FINANCIAL CORPORATION (NYSE:COF)
Shares purchased between February 2, 2018 and July 29, 2019
Deadline: December 2, 2019
On July 29, 2019, Capital One announced in a press release that it had suffered a data breach affecting over 106 million individuals in the United States and Canada. On this news, shares of Capital One fell $5.71 or nearly 5.9% to close at $91.21 on July 30 2019.
According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) the Company did not maintain robust information security protections, and its protection did not shield personal information against security breaches; (2) such deficiencies heightened the Company's exposure to a cyber-attack; and (3) as a result, Capital One's public statements were materially false and misleading at all relevant times.
Additional information can be found at http://www.brodskysmith.com/cases/capital-one-financial-corporation-nyse-cof/, or call 877-534-2590. No cost or obligation to you.
Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.
SOURCE: Brodsky & Smith, LLC
View source version on accesswire.com:
https://www.accesswire.com/563687/CLASS-ACTION-DEADLINES-Brodsky-Smith-LLC-Reminds-Investors-of-Deadlines-to-File-Lead-Plaintiff-Motions-Related-to-the-Following-Companies-MTCH-MYGN-COF
